Future Market Insights (FMI), a leading provider of market intelligence and consulting services, today released its comprehensive analysis of the United States Interventional Radiology Market. The report forecasts the market to expand from USD 11.3 billion in 2025 to USD 18.4 billion by 2035, achieving a compound annual growth rate (CAGR) of 4.9%. This growth underscores interventional radiology’s pivotal role as a cornerstone of modern, patient-centered healthcare, delivering minimally invasive alternatives that prioritize precision, reduced recovery times, and improved outcomes.
Interventional radiology (IR) continues to redefine treatment paradigms by leveraging advanced imaging technologies to guide procedures such as angioplasty, stenting, biopsies, and embolizations. These techniques offer significant advantages over traditional open surgery, including lower risks, shorter hospital stays, and faster patient recovery—making IR an increasingly preferred option for managing chronic conditions like cardiovascular diseases, cancer, and neurological disorders.
According to the FMI report, MRI systems are poised to dominate the product segment, commanding a 39.2% market share due to their superior imaging capabilities and versatility in guiding complex interventions. In the procedure category, angioplasty leads with a 25.0% share, driven by the escalating prevalence of cardiovascular conditions and the demand for effective, non-surgical vascular treatments.
Regional dynamics highlight robust expansion across the U.S., with the West region leading at a CAGR of 5.7%, followed by the South at 5.1%, Northeast at 4.5%, and Midwest at 4.0%. This geographic variation reflects differences in healthcare infrastructure, population demographics, and adoption rates of advanced technologies.
Key drivers fueling this market trajectory include the rising incidence of chronic diseases amid an aging population, technological advancements in imaging modalities like CT scanners, ultrasound systems, and angiography, and a broader shift toward cost-effective outpatient procedures. Ambulatory surgical centers (ASCs) and clinics are emerging as vital end users, capitalizing on IR’s efficiency to handle increasing procedure volumes outside traditional hospital settings.
“The U.S. interventional radiology market exemplifies healthcare innovation at its finest,” said a senior analyst at Future Market Insights. “As providers and payers alike prioritize value-based care, IR stands out for its ability to deliver high-precision therapies with minimal disruption to patients’ lives. From oncology interventions like tumor ablation to cardiology staples such as thrombolysis and vertebroplasty, these procedures are not just treating diseases—they’re transforming patient experiences.”
The report segments the market by product (including MRI systems, CT scanners, ultrasound imaging, angiography systems, and supporting devices); procedure (angioplasty, biopsy, embolization, thrombolysis, vertebroplasty, nephrostomy, interventional oncology, and musculoskeletal interventions); application (cardiology, oncology, urology, gastroenterology, obstetrics, gynecology, and others); and end user (hospitals, clinics, ASCs, and diagnostic centers).
Leading industry players—such as Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, and Hitachi Medical Corporation—are driving competition through investments in AI-integrated imaging, real-time guidance tools, and enhanced catheter technologies. These innovations are expanding IR’s scope into emerging areas like personalized medicine, chronic pain management, and targeted drug delivery.
While opportunities abound in oncology and outpatient care, challenges persist, including high equipment costs, the need for specialized training, and reimbursement complexities. However, ongoing advancements and a growing emphasis on minimally invasive therapies are expected to mitigate these barriers, paving the way for broader adoption.
Subscribe for Year-Round Insights → Stay ahead with quarterly and annual data updates: https://www.futuremarketinsights.com/reports/brochure/rep-gb-29678
Request for Discount: https://www.futuremarketinsights.com/reports/sample/rep-gb-29678
This steady, decision-grade growth trajectory positions interventional radiology as an industry leader in shaping the future of U.S. healthcare. Stakeholders—from hospital administrators to device manufacturers—can leverage these insights to inform strategic investments, partnerships, and innovation roadmaps.
The full report, “Demand for Interventional Radiology in USA | Market Analysis Report – 2035,” provides in-depth forecasts, competitive landscapes, and actionable recommendations. It is available now on the Future Market Insights website.
About Future Market Insights (FMI)
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.
Why FMI: Decisions that Change Outcomes- https://www.futuremarketinsights.com/why-fmi
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
Have a specific Requirements and Need Assistant on Report Pricing or Limited Budget please contact us – [email protected]
